Valuing non-marginal changes in mortality and morbidity risk
- PMID: 35569207
- DOI: 10.1016/j.jhealeco.2022.102627
Valuing non-marginal changes in mortality and morbidity risk
Abstract
Many stated-preference studies that seek to estimate the marginal willingness-to-pay (WTP) for reductions in mortality or morbidity risk suffer from inadequate scope sensitivity. One possible reason is that the risk reductions presented to respondents are too small to be meaningful. Survey responses may thus not accurately reflect respondents preferences for health and safety. In this paper we propose a novel approach to estimating the value per statistical life (VSL) or the value per statistical case (VSC) based on larger risk reductions measurable as percent changes. While such non-marginal risk reductions are easier to understand, they introduce well known biases. We propose a methodology to de-bias VSL and VSC estimates derived from the evaluation of non-marginal risk reductions and present a proof of concept using simulated stated preference data.
Keywords: Non-marginal risks reductions; Scope sensitivity; Value per statistical case; Value per statistical life.
Copyright © 2022. Published by Elsevier B.V.
Similar articles
-
Valuing mortality risk reductions from environmental, transport, and health policies: a global meta-analysis of stated preference studies.Risk Anal. 2011 Sep;31(9):1381-407. doi: 10.1111/j.1539-6924.2011.01694.x. Risk Anal. 2011. PMID: 21957946
-
Valuing mortality risk reductions in a fast-developing society: A meta-analysis of stated preference studies in China from 1998 to 2019.Soc Sci Med. 2024 Dec;363:117471. doi: 10.1016/j.socscimed.2024.117471. Epub 2024 Nov 6. Soc Sci Med. 2024. PMID: 39566224 Review.
-
The benefits of avoiding cancer (or dying from cancer): Evidence from a four- country study.J Health Econ. 2018 Jan;57:249-262. doi: 10.1016/j.jhealeco.2017.08.004. Epub 2017 Aug 19. J Health Econ. 2018. PMID: 28864334
-
Valuing mortality risk in the time of COVID-19.J Risk Uncertain. 2020;61(2):129-154. doi: 10.1007/s11166-020-09338-1. Epub 2020 Nov 11. J Risk Uncertain. 2020. PMID: 33199940 Free PMC article.
-
Willingness to pay for a QALY: theoretical and methodological issues.Pharmacoeconomics. 2005;23(5):423-32. doi: 10.2165/00019053-200523050-00002. Pharmacoeconomics. 2005. PMID: 15896094 Review.
Cited by
-
The economic value of reducing avoidable mortality.Nat Med. 2024 Nov;30(11):3327-3334. doi: 10.1038/s41591-024-03253-7. Epub 2024 Sep 27. Nat Med. 2024. PMID: 39333313
MeSH terms
LinkOut - more resources
Full Text Sources